Home Newsfeeds Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.

Protagenic Therapeutics Successfully Concludes Third Cohort In Single Dose Portion Of Phase 1 Trial For Stress-Related Neuropsychiatric Disorders

By Benzinga Newsdesk

March 27, 8:51 AM

Next clinical progress update expected in April 2024NEW YORK, NY / ACCESSWIRE / March 27, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a leader in biopharmaceutical innovation, advances its mission to develop

PTIX

News

Forge Global Added To U.S. Small-Cap Russell 2000 Index

By Happy Mohamed

June 26, 8:38 AM

Forge Global Holdings, Inc. ("Forge," or the "Company") (NYSE:FRGE), a leading private securities marketplace, today announced that it has been added as a member of the U.S. Small-Cap Russell

FRGE

‘Pharmageddon’ – Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report

By Shivani Kumaresan

October 30, 11:22 AM

Beginning Monday, pharmacy employees from leading chains such as CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and Rite Aid Corp (OTC:

CVS

‘Purest’ Crypto-Equity Play That Has 36% Upside: Analyst Says Buy Here

By AJ Fabino

March 27, 3:27 PM

MicroStrategy Inc (NASDAQ: MSTR) caught the eye of Benzinga analyst Gianni Di Poce, after the crypto-friendly company repaid the outstanding principal balance on its $205 million loan from crypto lender Silvergate Capital Corp (NYSE:

BTC

Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Related Posts

Protagenic Therapeutics Successfully Concludes Third Cohort In Single Dose Portion Of Phase 1 Trial For Stress-Related Neuropsychiatric Disorders

Forge Global Added To U.S. Small-Cap Russell 2000 Index

‘Pharmageddon’ – Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report

‘Purest’ Crypto-Equity Play That Has 36% Upside: Analyst Says Buy Here